share_log

XORTX Therapeutics Inc: AB FORM 13-501F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)

SEDAR ·  Apr 30, 2019 03:54
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more